Cargando…

Human cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transfer

Modulation of the immune system by genetically modified immunological effector cells is of potential therapeutic value in the treatment of malignancies. Interleukin-2 (IL-2) is a crucial cytokine which induces potent antitumor response. Cytokine-induced killer cells (CIK) have been described as high...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagaraj, Srinivas, Ziske, Carsten, Schmidt-Wolf, Ingo GH
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Short Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC516021/ https://www.ncbi.nlm.nih.gov/pubmed/15329148 http://dx.doi.org/10.1186/1479-0556-2-12

Ejemplares similares

Cytokine-induced killer cells are type II natural killer T cells
por: Gütgemann, Stefan, et al.
Publicado: (2007)

Primary small cell carcinoma of the esophagus: patient data metaanalysis and review of the literature
por: Al Mansoor, Saineb, et al.
Publicado: (2013)

Effect of chaetocin on renal cell carcinoma cells and cytokine-induced killer cells
por: Rombo, Roman, et al.
Publicado: (2016)

Increase of Antitumoral Effects of Cytokine-Induced Killer Cells by Antibody-Mediated Inhibition of MICA Shedding
por: Wu, Xiaolong, et al.
Publicado: (2020)

Effects of recombinant adenovirus-mediated expression of IL-2 and IL-12 in human B lymphoma cells on co-cultured PBMC
por: Ebert, Oliver, et al.
Publicado: (2004)

Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer
por: Dehno, Mojgan Naghizadeh, et al.
Publicado: (2020)

Tumour necrosis factor-alpha enhances the cytolytic and cytostatic capacity of interleukin-2 activated killer cells.
por: Matossian-Rogers, A., et al.
Publicado: (1989)

High-dose chemotherapy with autologous peripheral blood stem cell support for recurrent primary AFP-producing intracranial germinoma
por: Ziske, Carsten, et al.
Publicado: (2003)

PD-1 blockade enhances cytokine-induced killer cell-mediated cytotoxicity in B-cell non-Hodgkin lymphoma cell lines
por: Li, Yutao, et al.
Publicado: (2021)

Adoptive Immunotherapy Strategies with Cytokine-Induced Killer (CIK) Cells in the Treatment of Hematological Malignancies
por: Schmeel, Frederic Carsten, et al.
Publicado: (2014)

Natural Killer T Cells Subsets in Cancer, Functional Defects in Prostate Cancer and Implications for Immunotherapy
por: Nowak, Michael, et al.
Publicado: (2011)

Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood
Publicado: (1990)

Chronic infusion of interleukin‐17 promotes hypertension, activation of cytolytic natural killer cells, and vascular dysfunction in pregnant rats
por: Travis, Olivia K., et al.
Publicado: (2019)

The Effects of Artemisinin on the Cytolytic Activity of Natural Killer (NK) Cells
por: Houh, Youn Kyung, et al.
Publicado: (2017)

Invasive fungal infections in neutropenic enterocolitis: A systematic analysis of pathogens, incidence, treatment and mortality in adult patients
por: Gorschlüter, Marcus, et al.
Publicado: (2006)

Increased Efficacy of Brentuximab Vedotin (SGN-35) in Combination with Cytokine-Induced Killer Cells in Lymphoma
por: Esser, Laura, et al.
Publicado: (2016)

High Expression of Cannabinoid Receptor 2 on Cytokine-Induced Killer Cells and Multiple Myeloma Cells
por: Garofano, Francesca, et al.
Publicado: (2020)

GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo
por: Lim, Okjae, et al.
Publicado: (2013)

Aurantii Fructus Immaturus enhances natural killer cytolytic activity and anticancer efficacy in vitro and in vivo
por: Park, Arum, et al.
Publicado: (2022)

Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell Carcinoma
por: Zhang, Ying, et al.
Publicado: (2020)

Cytokine Induced Killer Cells as Promising Immunotherapy for Solid Tumors
por: Sangiolo, Dario
Publicado: (2011)

Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Gastrointestinal Tumors
por: Jäkel, Clara E., et al.
Publicado: (2014)

Human Immunodeficiency Syndromes Affecting Human Natural Killer Cell Cytolytic Activity
por: Ham, Hyoungjun, et al.
Publicado: (2014)

An optimal control approach for enhancing natural killer cells' secretion of cytolytic molecules
por: Makaryan, Sahak Z., et al.
Publicado: (2020)

Natural killer cytolytic activity is associated with the expression of killer cell immunoglobulin-like receptors on peripheral lymphocytes in human.
por: Kogure, Toshiaki, et al.
Publicado: (2003)

Clinical Studies on Cytokine-Induced Killer Cells: Lessons from Lymphoma Trials
por: Zhang, Ying, et al.
Publicado: (2021)

Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy
por: Garofano, Francesca, et al.
Publicado: (2019)

Cytokine-enhanced cytolytic activity of exosomes from NK Cells
por: Enomoto, Yutaka, et al.
Publicado: (2021)

Revising the Landscape of Cytokine-Induced Killer Cell Therapy in Lung Cancer: Focus on Immune Checkpoint Inhibitors
por: Vaseq, Rohulla, et al.
Publicado: (2023)

Stat5b Is Essential for Natural Killer Cell–mediated Proliferation and Cytolytic Activity
por: Imada, Kazunori, et al.
Publicado: (1998)

Oral Administration of Silk Peptide Enhances the Maturation and Cytolytic Activity of Natural Killer Cells
por: Jang, Sun-Hee, et al.
Publicado: (2018)

Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19
por: Osman, Mohammed, et al.
Publicado: (2020)

Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell Carcinoma
por: Jäkel, Clara E., et al.
Publicado: (2012)

Direct transfer of antigen-specific cytolytic activity to noncytolytic cells upon fusion with liposomes derived from cytolytic T cell clones
Publicado: (1984)

Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions
por: Jung, Daun, et al.
Publicado: (2021)

In Vivo Expression of Natural Killer Cell Inhibitory Receptors by Human Melanoma–Specific Cytolytic T Lymphocytes
por: Speiser, Daniel E., et al.
Publicado: (1999)

Rapid Lytic Granule Convergence to the MTOC in Natural Killer Cells Is Dependent on Dynein But Not Cytolytic Commitment
por: Mentlik, Ashley N., et al.
Publicado: (2010)

Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells
por: Van Acker, Heleen H., et al.
Publicado: (2017)

Improved Activation toward Primary Colorectal Cancer Cells by Antigen-Specific Targeting Autologous Cytokine-Induced Killer Cells
por: Schlimper, Claudia, et al.
Publicado: (2012)

Augmentation of Cytolytic Activity in Murine Natural Killer Cells and Inhibition of Tumor Growth by the Ethanol Fraction of Oyster Extract
por: Sakaguchi, Kaito, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qf0aq14cfd1dl2dmrfagpunpsr